谷歌浏览器插件
订阅小程序
在清言上使用

First-in-human Phase 1A Study of RGT-419B, a Next Generation CDK4 Inhibitor, in Patients (pts) with Hormone Receptor Positive (HR+) HER2advanced/metastatic Breast Cancer (ABC) Who Progressed on Prior CDK4/6 Inhibitors (Cdk4/6i)

Seth Wander, Dave Valacer,Richard Zuniga,Heather Yeckes-Rodin, Christopher Perkins, Lisa Ge,Lili Yao,Jing Lin, Dawn Begley, Feifei Sun, Andie Zheng, Jing Han, Zhi (Julie) Xie,Aditya Bardia,Kevin Kalinsky

CANCER RESEARCH(2024)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要